Crohn's and Colitis Foundation
45
4
5
25
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
15.6%
7 terminated/withdrawn out of 45 trials
78.1%
-8.4% vs industry average
7%
3 trials in Phase 3/4
52%
13 of 25 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (45)
Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
Role: collaborator
Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease
Role: collaborator
TUDCA as a Therapy for Ulcerative Colitis (UC)
Role: collaborator
Nicotinamide Riboside in Ulcerative Colitis
Role: collaborator
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
Role: collaborator
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Role: collaborator
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
Role: collaborator
Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)
Role: collaborator
Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease
Role: collaborator
Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis
Role: collaborator
Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
Role: collaborator
Addressing Disability Effectively With Psychosocial Telemedicine
Role: collaborator
Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)
Role: collaborator
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Role: collaborator
Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Role: collaborator
Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.
Role: collaborator
AppenDectomy Vs ANti TNF-a in Inducing Clinical and EnDoscopic Remission in Left-sided Ulcerative Colitis
Role: collaborator
CBT-I for Sleep, Pain, and Inflammation in Crohn's Disease
Role: collaborator
Biomarkers to Predict and Monitor Response to Infliximab
Role: collaborator
Can Intermittent Fasting Induce Weight Loss and Improve Gut Health as Compared to Standard Medical Care in Patients With Obesity/High BMI and Crohn's Disease.
Role: collaborator